Redhill Biopharma Ltd
NASDAQ:RDHL
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RDHL's stock price target?
Not Available
RDHL doesn't have any price targets made by Wall Street professionals.
What is Redhill Biopharma Ltd's Revenue forecast?
Projected CAGR
144%
The compound annual growth rate of Redhill Biopharma Ltd's revenue for the next 2 years is 144%.